4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-009508
Chief Executive Officer sold 7,800 shares at an average $38.77 ($302,367)
- Chief Executive Officer gave up 20,324 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2019-02-09 | Shares withheld for taxes | −20,324 | $38.49 | $782,271 | 334,618 | D |
| Ciechanover Isaac E. Chief Executive Officer | 2019-02-11 | Sale | −3,900 | $38.52 | $150,228 | 346,038 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2019-02-12 | Sale | −3,900 | $39.01 | $152,139 | 342,138 | I |
| Open-market sales · 7,800 sh · avg $38.77 · $302,367 | |||||||
Loading xslF345X03/doc4.xml…